This site is intended for healthcare professionals only
LoginRegister
Sun Pharma Rules Out Big-Bang Acquisitions, Bets on Organic Growth and BiosimilarsSun Pharma Agrees to Halt India Sales of Semaglutide After Delhi HC Records Patent Undertaking
Biocon Secures USFDA Nod for Generic Liraglutide Prefilled Pens for DiabetesS&P Global places Biocon Biologics on positive CreditWatch on account of accelerated debt reduction
Unrestricted Antibiotic Sales via E-Pharmacies: AIOCD Flags AMR Risk, Seeks PM Modis InterventionMedicines Aren't Groceries: AIOCD Urges PM to Shut Down Illegal Online Pharmacies After Blinkit...
Haryana Pharmacy Council Extends Registration Validity for 2022-23 D.Pharm Batch Till December 2026PCI Begins Direct Certificate Issuance in Gujarat Amid Confusion Over Pharmacy Exit Exam
Prior Intimation System Under NDCT Rules Wont Apply to Hormones, Cytotoxics, Beta-Lactams, Certain Biologics: CDSCOSuven Ropanicant Phase-2b trial for Major Depressive Disorder achieves 100 percent enrollment ahead...
medicinesGovt Panel Proposes Separate Licensing System for Bulk Drugs and Excipients Wholesalers
After 40 Years, USFDA Approves Vanda Pharmas Motion Sickness Drug NereusAlembic Pharma wins USFDA nod for Loteprednol Etabonate and Tobramycin Ophthalmic Suspension
USFDA Grants Fast-Track Nod to Boehringer Ingelheims Zongertinib for Rare Lung CancerBoehringer Ingelheim Jascayd receives regulatory approval for progressive pulmonary fibrosis in...
GSK Pharma CFO Juby Chandy Resigns, Moves to Asia Pacific Finance Head RoleGSK risvutatug rezetecan gets USFDA Orphan Drug Designation for lung cancer
CDSCO Cancels Kult Apps Cosmetic Import Registrations Over False LabelingKerala Blocks 17 Faulty Medicines Including Rabeprazole, Ciprofloxacin After Counterfeit Seizure
Indian Pharma Market Posts 9% Surge in November Even as Volumes Stay Flat: PharmaTracIndian Pharma Market Posts 9% Surge in November Even as Volumes Stay Flat: PharmaTrac
CDSCO Panel Flags Gaps in Serum Institutes rBCG Vaccine Data, Calls for Stronger TrialCDSCO Panel Flags Gaps in Serum Institute's rBCG Vaccine Data, Calls for Stronger Trial
X